All products developed by Wellspect undergo clinical study programs whereby products' safety and performance are carefully evaluated and determined. Our clinical study programs are developed and conducted with lead clinicians in the field and in accordance with Good Clinical Practice (GCP).
Together we can advance continence care
Advancing continence care is a joint endeavor between health care professionals, researchers and MedTech companies that are active in the field of continence care. Together, we can develop the next generation of bladder and bowel products and make a real difference in the lives of people who depend on such products.
To explore the synergies between bowel and bladder, we initiated the ACCT global forum (Advancing Continence Care Together) in 2017. Under the umbrella of this forum, a number of scientific webinars of various themes, are organized annually.
Separately, we also conduct our own scientific research and fund clinical trials and Investigator Initiated Studies (IIS).
All funding applications for study grants and Investigator Initiated Studies (IIS), are reviewed and processed by Wellspect's head office in Sweden. Applicants from around the world are welcome to apply to both.
The main purpose of the IIS Programme is to increase and stimulate external research into products, therapies and clinical management. The programme is coordinated by external healthcare professionals with support from Wellspect.
Are you a nurse dedicated to helping patients with bladder or bowel problems? Do you want to advance continence care and improve patients' care? Why not consider applying for one of our study grants.